167 related articles for article (PubMed ID: 24871900)
1. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
Sashidhara KV; Dodda RP; Sonkar R; Palnati GR; Bhatia G
Eur J Med Chem; 2014 Jun; 81():499-509. PubMed ID: 24871900
[TBL] [Abstract][Full Text] [Related]
2. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents.
Sashidhara KV; Palnati GR; Dodda RP; Sonkar R; Khanna AK; Bhatia G
Eur J Med Chem; 2012 Nov; 57():302-10. PubMed ID: 23078966
[TBL] [Abstract][Full Text] [Related]
3. Hybrid benzofuran-bisindole derivatives: new prototypes with promising anti-hyperlipidemic activities.
Sashidhara KV; Modukuri RK; Sonkar R; Rao KB; Bhatia G
Eur J Med Chem; 2013 Oct; 68():38-46. PubMed ID: 23954239
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.
Pandeti S; Sonkar R; Shukla A; Bhatia G; Tadigoppula N
Eur J Med Chem; 2013 Nov; 69():439-48. PubMed ID: 24090915
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antidyslipidemic activity of chalcone fibrates.
Shukla P; Srivastava SP; Srivastava R; Rawat AK; Srivastava AK; Pratap R
Bioorg Med Chem Lett; 2011 Jun; 21(11):3475-8. PubMed ID: 21515043
[TBL] [Abstract][Full Text] [Related]
6. Indole-based fibrates as potential hypolipidemic and antiobesity agents.
Sashidhara KV; Kumar M; Sonkar R; Singh BS; Khanna AK; Bhatia G
J Med Chem; 2012 Mar; 55(6):2769-79. PubMed ID: 22339404
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new N-acryl-1-amino-2-phenylethanol and N-acyl-1-amino-3-aryloxypropanols and evaluation of their antihyperlipidemic, LDL-oxidation and antioxidant activity.
Sarkar S; Sonkar R; Bhatia G; Tadigoppula N
Eur J Med Chem; 2014 Jun; 80():135-44. PubMed ID: 24769351
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation.
Hassan RM; Aboutabl ME; Bozzi M; El-Behairy MF; El Kerdawy AM; Sampaolese B; Desiderio C; Vincenzoni F; Sciandra F; Ghannam IAY
Bioorg Chem; 2021 Oct; 115():105170. PubMed ID: 34332233
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in Vivo Lipid-Lowering Activity of Novel Imidazoles-5-carboxamide Derivatives in Triton-WR-1339-Induced Hyperlipidemic Wistar Rats.
Jasim SH; Abu Sheikha GM; Abuzaid HM; Al-Qirim TM; Shattat GF; Sabbah DA; Ata SA; Ala SA; Aboumair MS; Sweidan KA; Bkhaitan MM
Chem Pharm Bull (Tokyo); 2018; 66(10):953-958. PubMed ID: 30270241
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Novel Benzimidazole-2-carboxamide Derivatives and in Vivo Antihyperlipidemic Activity Evaluation.
Sheikha GA; Bkhaitan MM; Kalloush H; Hamadneh L; Khalaf RA; Al-Qirim T; Al-Hiari Y
Chem Pharm Bull (Tokyo); 2018; 66(4):423-426. PubMed ID: 29607907
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of some 2-azetidinone derivatives as potential antihyperlipidemic agents.
Arya N; Dwivedi J; Khedkar VM; Coutinho EC; Jain KS
Arch Pharm (Weinheim); 2013 Dec; 346(12):872-81. PubMed ID: 24142910
[TBL] [Abstract][Full Text] [Related]
12. Novel keto-enamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2H-benzo[h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents.
Sashidhara KV; Rosaiah JN; Bhatia G; Saxena JK
Eur J Med Chem; 2008 Nov; 43(11):2592-6. PubMed ID: 18063225
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological effects of novel 5-fluoro-N-(9,10-dihydro-9,10-dioxoanthracen-8-yl)-1H-indole-2-carboxamide derivatives on plasma lipid profile of Triton-WR-1339-induced Wistar rats.
Shattat G; Al-Qirim T; Sheikha GA; Al-Hiari Y; Sweidan K; Al-Qirim R; Hikmat S; Hamadneh L; Al-Kouz S
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):863-9. PubMed ID: 22651797
[TBL] [Abstract][Full Text] [Related]
14. Coumarin chalcone fibrates: a new structural class of lipid lowering agents.
Sashidhara KV; Palnati GR; Sonkar R; Avula SR; Awasthi C; Bhatia G
Eur J Med Chem; 2013 Jun; 64():422-31. PubMed ID: 23665798
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-hyperlipidemic evaluation of N‑(benzoylphenyl)-5-fluoro-1H-indole-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats.
Shattat G; Al-Qirim R; Al-Hiari Y; Sheikha GA; Al-Qirim T; El-Huneidi W; Shahwan M
Molecules; 2010 Aug; 15(9):5840-9. PubMed ID: 21330955
[TBL] [Abstract][Full Text] [Related]
16. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
Tooulia KK; Theodosis-Nobelos P; Rekka EA
Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
[TBL] [Abstract][Full Text] [Related]
17. Antihyperlipidemic properties of novel N-(benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-induced hyperlipidemic rats.
Al-Hiari Y; Shattat G; Al-Qirim T; El-Huneidi W; Sheikha GA; Hikmat S
Molecules; 2011 Sep; 16(10):8292-304. PubMed ID: 21959300
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones.
Arya N; Munde MK; Dwivedi J; Jagdale AY; Jain KS
Arch Pharm (Weinheim); 2013 Aug; 346(8):588-95. PubMed ID: 23881664
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel N-(2-hydroxy-2-p-tolylethyl)-amide and N-(2-oxo-2-p-tolylethyl)-amide derivatives and their antidyslipidemic and antioxidant activity.
Narender T; Rajendar K; Sarkar S; Singh VK; Chaturvedi U; Khanna AK; Bhatia G
Bioorg Med Chem Lett; 2011 Nov; 21(21):6393-7. PubMed ID: 21930379
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Evaluation of Novel Isonicotinic Carboxamide Derivatives as Potential Anti-Hyperlipidemic and Antioxidant Agents.
Abu Farha R; Bustanji Y; Al-Hiari Y; Bardaweel S; Al-Qirim T; Abu Sheikha G; Albashiti R
Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28837755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
